Related references
Note: Only part of the references are listed.Regulation of Ligands for the NKG2D Activating Receptor
David H. Raulet et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Immune modulation of T-cell and NK (natural killer) cell activities by TEXs (tumour-derived exosomes)
Theresa L. Whiteside
BIOCHEMICAL SOCIETY TRANSACTIONS (2013)
Gut microbiota regulates NKG2D ligand expression on intestinal epithelial cells
Camilla H. F. Hansen et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: Heterogeneous involvement of the a disintegrin and metalloproteases 10 and 17
Guranda Chitadze et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Epithelial-Mesenchymal Transition Induces an Antitumor Immune Response Mediated by NKG2D Receptor
Alejandro Lopez-Soto et al.
JOURNAL OF IMMUNOLOGY (2013)
Regulation of NKG2D-ligand cell surface expression by intracellular calcium after HDAC-inhibitor treatment
Helle Jensen et al.
MOLECULAR IMMUNOLOGY (2013)
Natural cytotoxicity receptors: broader expression patterns and functions in innate and adaptive immune cells
Kelly Hudspeth et al.
FRONTIERS IN IMMUNOLOGY (2013)
Metastamir-mediated immune evasion miR-10b downregulates the stress-induced molecule MICB, hence avoid recognition by NKG2D receptor
Pinchas Tsukerman et al.
ONCOIMMUNOLOGY (2013)
Interleukin-1β enhances the production of soluble MICA in human hepatocellular carcinoma
Keisuke Kohga et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Tumor Suppressive MicroRNAs miR-34a/c Control Cancer Cell Expression of ULBP2, a Stress-Induced Ligand of the Natural Killer Cell Receptor NKG2D
Anja Heinemann et al.
CANCER RESEARCH (2012)
MiR-10b Downregulates the Stress-Induced Cell Surface Molecule MICB, a Critical Ligand for Cancer Cell Recognition by Natural Killer Cells
Pinchas Tsukerman et al.
CANCER RESEARCH (2012)
Diagnostic and prognostic impact of serum-soluble UL16-binding protein 2 in lung cancer patients
Kosuke Yamaguchi et al.
CANCER SCIENCE (2012)
HER2/HER3 Signaling Regulates NK Cell-Mediated Cytotoxicity via MHC Class I Chain-Related Molecule A and B Expression in Human Breast Cancer Cell Lines
Riki Okita et al.
JOURNAL OF IMMUNOLOGY (2012)
Comprehensive Analysis of NKG2D Ligand Expression and Release in Leukemia: Implications for NKG2D-Mediated NK Cell Responses
Julia Hilpert et al.
JOURNAL OF IMMUNOLOGY (2012)
Human NKG23-ligands: cell biology strategies to ensure immune recognition
Lola Fernandez-Messina et al.
FRONTIERS IN IMMUNOLOGY (2012)
Valproic Acid Upregulates NKG2D Ligand Expression through an ERK-dependent Mechanism and Potentially Enhances NK Cell-mediated Lysis of Myeloma
Xiaosong Wu et al.
NEOPLASIA (2012)
Complex regulation of human NKG2D-DAP10 cell surface expression: opposing roles of the γc cytokines and TGF-β1
Yuk Pheel Park et al.
BLOOD (2011)
MMP9 mediates MICA shedding in human osteosarcomas
Dahui Sun et al.
CELL BIOLOGY INTERNATIONAL (2011)
Regulation of immune cell function and differentiation by the NKG2D receptor
Biljana Zafirova et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
Palmitoylation of MICA, a ligand for NKG2D, mediates its recruitment to membrane microdomains and promotes its shedding
Sonia Agüera-González et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
NKG2D performs two functions in invariant NKT cells: Direct TCR-independent activation of NK-like cytolysis and co-stimulation of activation by CD1d
Carlotta Kuylenstierna et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Activation of the Receptor NKG2D Leads to Production of Th17 Cytokines in CD4+ T Cells of Patients With Crohn's Disease
Benjamin Pariente et al.
GASTROENTEROLOGY (2011)
Structure/function of human killer cell immunoglobulin-like receptors: lessons from polymorphisms, evolution, crystal structures and mutations
Kerry S. Campbell et al.
IMMUNOLOGY (2011)
The human NKG2D ligand ULBP2 can be expressed at the cell surface with or without a GPI anchor and both forms can activate NK cells
Lola Fernandez-Messina et al.
JOURNAL OF CELL SCIENCE (2011)
CEACAM1 dampens antitumor immunity by down-regulating NKG2D ligand expression on tumor cells
Zhangguo Chen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Modulation of NKG2D-ligand Cell Surface Expression Enhances Immune Cell Therapy of Cancer
Baocheng Huang et al.
JOURNAL OF IMMUNOTHERAPY (2011)
Vis-a-Vis in the NKC: Genetically Linked Natural Killer Cell Receptor/Ligand Pairs in the Natural Killer Gene Complex (NKC)
Isabel Vogler et al.
JOURNAL OF INNATE IMMUNITY (2011)
Thermal- and Oxidative Stress Causes Enhanced Release of NKG2D Ligand-Bearing Immunosuppressive Exosomes in Leukemia/Lymphoma T and B Cells
Malin Hedlund et al.
PLOS ONE (2011)
Secretome-Based Identification of ULBP2 as a Novel Serum Marker for Pancreatic Cancer Detection
Ya-Ting Chang et al.
PLOS ONE (2011)
Vesicular Stomatitis Virus Infection Promotes Immune Evasion by Preventing NKG2D-Ligand Surface Expression
Helle Jensen et al.
PLOS ONE (2011)
Expression, signaling proficiency, and stimulatory function of the NKG2D lymphocyte receptor in human cancer cells
Andrea Caballero Benitez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Innate or Adaptive Immunity? The Example of Natural Killer Cells
Eric Vivier et al.
SCIENCE (2011)
ADAM-Mediated Shedding, A New Flavor in Angiogenesis Regulation
Lena Claesson-Welsh
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Natural Killer Cell Cytotoxicity Is Suppressed by Exposure to the Human NKG2D Ligand MICA*008 That Is Shed by Tumor Cells in Exosomes
Omodele Ashiru et al.
CANCER RESEARCH (2010)
Control of death receptor ligand activity by posttranslational modifications
R. Weinlich et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
ADAM-17: the enzyme that does it all
Monika Gooz
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2010)
Sorafenib Inhibits the Shedding of Major Histocompatibility Complex Class I-Related Chain A on Hepatocellular Carcinoma Cells by Down-Regulating a Disintegrin and Metalloproteinase 9
Keisuke Kohga et al.
HEPATOLOGY (2010)
Differential Mechanisms of Shedding of the Glycosylphosphatidylinositol (GPI)-anchored NKG2D Ligands
Lola Fernandez-Messina et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Intracellular Sequestration of the NKG2D Ligand ULBP3 by Human Cytomegalovirus
Neil J. Bennett et al.
JOURNAL OF IMMUNOLOGY (2010)
NKG2D Initiates Caspase-Mediated CD3ζ Degradation and Lymphocyte Receptor Impairments Associated with Human Cancer and Autoimmune Disease
Nobuyoshi Hanaoka et al.
JOURNAL OF IMMUNOLOGY (2010)
Cutting Edge: The Membrane Type Matrix Metalloproteinase MMP14 Mediates Constitutive Shedding of MHC Class I Chain-Related Molecule A Independent of A Disintegrin and Metalloproteinases
Gang Liu et al.
JOURNAL OF IMMUNOLOGY (2010)
The prognostic significance of soluble NKG2D ligands in B-cell chronic lymphocytic leukemia
H. Nueckel et al.
LEUKEMIA (2010)
Sodium valproate, a histone deacetylase inhibitor, augments the expression of cell-surface NKG2D ligands, MICA/B, without increasing their soluble forms to enhance susceptibility of human osteosarcoma cells to NK cell-mediated cytotoxicity
Koji Yamanegi et al.
ONCOLOGY REPORTS (2010)
Functional Dichotomy between NKG2D and CD28-Mediated Co-Stimulation in Human CD8+ T Cells
Kamalakannan Rajasekaran et al.
PLOS ONE (2010)
Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors
Yenan T. Bryceson et al.
BLOOD (2009)
Clinical significance of the NKG2D ligands, MICA/B and ULBP2 in ovarian cancer: high expression of ULBP2 is an indicator of poor prognosis
Kui Li et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Anticancer Chemotherapy Inhibits MHC Class I-Related Chain A Ectodomain Shedding by Downregulating ADAM10 Expression in Hepatocellular Carcinoma
Keisuke Kohga et al.
CANCER RESEARCH (2009)
Differential Clinical Significance of Individual NKG2D Ligands in Melanoma: Soluble ULBP2 as an Indicator of Poor Prognosis Superior to S100B
Annette Paschen et al.
CLINICAL CANCER RESEARCH (2009)
NKG2D Ligand Expression in Human Colorectal Cancer Reveals Associations with Prognosis and Evidence for Immunoediting
Roger W. McGilvray et al.
CLINICAL CANCER RESEARCH (2009)
Normally occurring NKG2D+CD4+ T cells are immunosuppressive and inversely correlated with disease activity in juvenile-onset lupus
Zhenpeng Dai et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Cutting Edge: Down-Regulation of MHC Class I-Related Chain A on Tumor Cells by IFN-gamma-Induced MicroRNA
Deepak Yadav et al.
JOURNAL OF IMMUNOLOGY (2009)
Cutting Edge: The Metalloproteinase ADAM17/TNF-α-Converting Enzyme Regulates Proteolytic Shedding of the MHC Class I-Related Chain B Protein
Philippe Boutet et al.
JOURNAL OF IMMUNOLOGY (2009)
Brief Residence at the Plasma Membrane of the MHC Class I-Related Chain B Is Due to Clathrin-Mediated Cholesterol-Dependent Endocytosis and Shedding
Sonia Agueera-Gonzalez et al.
JOURNAL OF IMMUNOLOGY (2009)
NKG2D-Dependent IL-17 Production by Human T Cells in Response to an Intracellular Pathogen
Padmaja Paidipally et al.
JOURNAL OF IMMUNOLOGY (2009)
Human Placenta Expresses and Secretes NKG2D Ligands via Exosomes that Down-Modulate the Cognate Receptor Expression: Evidence for Immunosuppressive Function
Malin Hedlund et al.
JOURNAL OF IMMUNOLOGY (2009)
NKG2D Ligand MICA Is Retained in the cis-Golgi Apparatus by Human Cytomegalovirus Protein UL142
Omodele Ashiru et al.
JOURNAL OF VIROLOGY (2009)
Effective in vivo induction of NKG2D ligands in acute myeloid leukaemias by all-trans-retinoic acid or sodium valproate
A. Poggi et al.
LEUKEMIA (2009)
Dendritic Cell-Derived Exosomes Promote Natural Killer Cell Activation and Proliferation: A Role for NKG2D Ligands and IL-15Rα
Sophie Viaud et al.
PLOS ONE (2009)
Cellular Expression, Trafficking, and Function of Two Isoforms of Human ULBP5/RAET1G
Robert A. Eagle et al.
PLOS ONE (2009)
The A Disintegrin And Metalloprotease (ADAM) family of sheddases: Physiological and cellular functions
Karina Reiss et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2009)
Induction of MHC class I-related chain B (MICB) by 5-aza-2′-deoxycytidine
Kai-Fu Tang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Synergistic inhibition with a dual epidermal growth factor receptor/HER-2/neu tyrosine kinase inhibitor and a disintegrin and metalloprotease inhibitor
Lois Witters et al.
CANCER RESEARCH (2008)
Tumor-associated MICA is shed by ADAM proteases
Inja Waldhauer et al.
CANCER RESEARCH (2008)
Line of attack: NK cell specificity and integration of signals
Yenan T. Bryceson et al.
CURRENT OPINION IN IMMUNOLOGY (2008)
Soluble NKG2D ligands: prevalence, release, and functional impact
Helmut Rainer Salih
Frontiers in Bioscience-Landmark (2008)
NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy
Nadia Guerra et al.
IMMUNITY (2008)
IL-18 enhances ULBP2 expression through the MAPK pathway in leukemia cells
Hyunkeun Song et al.
IMMUNOLOGY LETTERS (2008)
Tumor-derived soluble MICs impair CD3+CD56+ NKT-like cell cytotoxicity in cancer patients
Huiming Wang et al.
IMMUNOLOGY LETTERS (2008)
Human tumor-derived exosomes down-modulate NKG2D expression
Aled Clayton et al.
JOURNAL OF IMMUNOLOGY (2008)
Interaction of Monocytes with NK Cells upon Toll-Like Receptor-Induced Expression of the NKG2D Ligand MICA
Mercedes Kloss et al.
JOURNAL OF IMMUNOLOGY (2008)
The ADAMs: signalling scissors in the tumour microenvironment
Gillian Murphy
NATURE REVIEWS CANCER (2008)
Differentiation-promoting drugs up-regulate NKG2D ligand expression and enhance the susceptibility of acute myeloid leukemia cells to natural killer cell-mediated lysis
Andreas Rohner et al.
LEUKEMIA RESEARCH (2007)
Induction of NKG2D ligands on human dendritic cells by TLR ligand stimulation and RNA virus infection
Takashi Ebihara et al.
INTERNATIONAL IMMUNOLOGY (2007)
Lysis of a broad range of epithelial tumour cells by human γδ T cells:: Involvement of NK62D ligands and T-cell receptor- versus NKG2D-dependent recognition
P. Wrobel et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2007)
Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK-cell lysis
Cristina Cerboni et al.
BLOOD (2007)
RAET1E2, a soluble isoform of the UL16-binding protein RAET1E produced by tumor cells, inhibits NKG2D-mediated NK cytotoxicity
Wei Cao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands
Brett K. Kaiser et al.
NATURE (2007)
Soluble MIC is elevated in the serum of patients with pancreatic carcinoma diminishing γδ T cell cytotoxicity
Angela Maerten et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
TGF-β and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells
Guenter Eisele et al.
BRAIN (2006)
Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer
Bin-Bing S. Zhou et al.
CANCER CELL (2006)
NKG2D-mediated signaling requires a DAP10-bound Grb2-Vav1 intermediate and phosphatidylinositol-3-kinase in human natural killer cells
JL Upshaw et al.
NATURE IMMUNOLOGY (2006)
Proteolytic release of soluble UL16-binding protein 2 from tumor cells
I Waldhauer et al.
CANCER RESEARCH (2006)
Release of MICB molecules by tumor cells: Mechanism and soluble MICB in sera of cancer patients
Helmut Rainer Salih et al.
HUMAN IMMUNOLOGY (2006)
Expression of the NKG2D ligand UL16 binding protein-1 (ULBP-1) on dendritic cells
D Schrama et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion
YT Bryceson et al.
BLOOD (2006)
Soluble ULBP suppresses natural killer cell activity via down-regulating NKG2D expression
Hyunkeun Song et al.
CELLULAR IMMUNOLOGY (2006)
Activation of Vγ9Vδ2 T cells by NKG2D
B Rincon-Orozco et al.
JOURNAL OF IMMUNOLOGY (2005)
Adams: Key components in EGFR signalling and development
CP Blobel
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
NKP44 triggers NK cell activation through DAP12 association that is not influenced by a putative cytoplasmic inhibitory sequence
KS Campbell et al.
JOURNAL OF IMMUNOLOGY (2004)
Two human ULBP/RAET1 molecules with transmembrane regions are ligands for NKG2D
L Bacon et al.
JOURNAL OF IMMUNOLOGY (2004)
Roles of the NKG2D immunoreceptor and its ligands
DH Raulet
NATURE REVIEWS IMMUNOLOGY (2003)
NKG2D-DAP10 triggers human NK cell-mediated killing via a Syk-independent regulatory pathway
DD Billadeau et al.
NATURE IMMUNOLOGY (2003)
Intracellular retention of the MHC class I-related chain B ligand of NKG2D by the human cytomegalovirus UL16 glycoprotein
J Wu et al.
JOURNAL OF IMMUNOLOGY (2003)
Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation
V Groh et al.
NATURE (2002)
Cutting edge: Down-regulation of MICA on human tumors by proteolytic shedding
HR Salih et al.
JOURNAL OF IMMUNOLOGY (2002)
Expression of stress-induced MHC class I related chain molecules on human melanoma
CS Vetter et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2002)
MICA engagement by human Vγ2Vδ2 T cells enhances their antigen-dependent effector function
H Das et al.
IMMUNITY (2001)
Share Paper
